CorMedix Inc.
CRMDNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CRMD. That does not mean none is planned.
Get an email about CRMD's next catalysts
Track CorMedix (CRMD) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
CRMD Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.09 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
(taurolidine and heparin) catheter lock solution
Central Line Associated Blood Stream Infections (CLABSI)
Neutrolin
Kidney Failure, Chronic
CRMD-001-Deferiprone
Contrast-Induced Acute Kidney Injury
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(taurolidine and heparin) catheter lock solution | Phase 3 | Central Line Associated Blood Stream Infections (CLABSI) | - | - |
Neutrolin | Phase 3 | Kidney Failure, Chronic | - | - |
CRMD-001-Deferiprone | Phase 2 | Contrast-Induced Acute Kidney Injury | - | - |
Frequently asked questions
What is in CorMedix Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in CorMedix Inc.'s (CRMD) pipeline across Phase 3, Phase 2. Its lead program is (taurolidine and heparin) catheter lock solution (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CorMedix Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CorMedix Inc. (CRMD) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CRMD biotech catalysts?→
Add CRMD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CorMedix Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.